Ladenburg Thalmann Financial Services’s Epizyme, Inc EPZM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$2K Buy
+68
New +$1.01K ﹤0.01% 5133
2018
Q4
Sell
-250
Closed -$3K 5406
2018
Q3
$3K Sell
250
-200
-44% -$2.28K ﹤0.01% 4817
2018
Q2
$8K Hold
450
﹤0.01% 4401
2018
Q1
$8K Hold
450
﹤0.01% 4401
2017
Q4
$6K Sell
450
-112
-20% -$1.63K ﹤0.01% 4470
2017
Q3
$11K Buy
562
+450
+402% +$6.87K ﹤0.01% 4053
2017
Q2
$2K Hold
112
﹤0.01% 4641
2017
Q1
$2K Buy
112
+3
+3% +$40 ﹤0.01% 4613
2016
Q4
$1K Hold
109
﹤0.01% 4745
2016
Q3
$1K Buy
+109
New +$995 ﹤0.01% 4691

Other funds holding EPZM

Ladenburg Thalmann Financial Services's EPZM Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services opened a new position in Epizyme, Inc (EPZM) in Q4 2019: 68 shares worth $2K. The stake represents ﹤0.01% of the portfolio and ranks #5133 among its holdings. This is a return to the name: Ladenburg Thalmann Financial Services previously reported a position in EPZM as recently as Q3 2018.

Ladenburg Thalmann Financial Services first reported a position in EPZM in Q3 2016 and has held it in 10 quarters since. The position peaked at $11K in Q3 2017. 136 funds tracked by Wall St. Rank hold EPZM as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 68 shares of Epizyme, Inc worth $2K as of Q4 2019.
  • Epizyme, Inc was a new Ladenburg Thalmann Financial Services position in Q4 2019.
  • Epizyme, Inc made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #5133 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Epizyme, Inc in Q3 2016 and has held it in 10 quarters since.
  • Ladenburg Thalmann Financial Services's Epizyme, Inc position peaked at $11K in Q3 2017.
  • 136 funds tracked by Wall St. Rank held Epizyme, Inc as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.